January 11, 2018Open Access
Plasma neurofilament light chain concentration in the inherited peripheral neuropathies
Key Points
Key points are not available for this paper at this time.
Abstract
There are currently no validated blood biomarkers for peripheral neuropathy. The significantly raised plasma NfL concentration in patients with CMT and its correlation with disease severity suggest that plasma NfL holds promise as a biomarker of disease activity, not only for inherited neuropathies but for peripheral neuropathy in general.